Valuation GC Genome Corporation

Stocks

End-of-day quote Korea S.E. Other stock markets 2026-07-13			5-day change	1st Jan Change
4,450.00 ^KRW	-6.71%		-8.44%	-34.75%

12-09	GC Genome Study Identifies 'Confounders' Interfering with Cancer Signals to Improve Liquid Biopsy Accuracy	CI
25-06-12	GC Genome Shares Decline Nearly 3% After Strong Kosdaq Debut	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2025	2026	2027
Market Cap ¹	161,298	105,246	-
Change	-	-34.75%	-
Enterprise Value (EV) ¹	161.3	45.85	36.45
Change	-	-71.58%	-20.5%
P/E	36.9x	-	-
PBR	-	-	-
PEG	-0x	-	-
Capitalization / Revenue	-	2.7x	2.16x
EV / Revenue	-	1.18x	0.75x
EV / EBITDA	-	-	-
EV / EBIT	-	11.5x	5.21x
EV / FCF	-	-	-
FCF Yield	-	-	-
Dividend per Share ³	-	-	-
Rate of return	-	-	-
EPS ³	185	-	-
Distribution rate	-	-	-
Net sales ¹	-	39	48.8
EBITDA	-	-	-
EBIT ¹	-	4	7
Net income	4.044	-	-
Net Debt ¹	-	-59.4	-68.8
Reference price ³	6,820.00	4,450.00	4,450.00
Nbr of stocks (in thousands)	23,651	23,651	-
Announcement Date	3/16/26	-	-

¹KRW in Million²KRW in Billions³KRW

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
GC GENOME CORPORATION	-	1.37x	-	-	70.48M
NATERA, INC.	-162.47x	13.45x	-183.51x	-.--%	39.08B
LABCORP HOLDINGS INC.	19.1x	1.86x	10.7x	1.05%	22.69B
SONIC HEALTHCARE LIMITED	17.02x	1.33x	7.56x	5.11%	7.17B
RADNET, INC.	336.41x	-	-	-	4.98B
DR. LAL PATHLABS LIMITED	48.03x	8.54x	30.33x	1.08%	3.01B
GENEDX HOLDINGS CORP.	-21.9x	-	-	-	1.9B
DIAN DIAGNOSTICS GROUP CO.,LTD.	32.09x	1.15x	9.57x	0.79%	1.82B
NEOGENOMICS, INC.	-31.66x	-	-	-.--%	1.84B
FLEURY S.A.	12.91x	1.34x	5.24x	5.86%	1.71B
Average	27.73x	4.15x	-20.02x	1.98%	8.43B
Weighted average by Cap.	-47.43x	8.04x	-89.51x	0.97%